Page 143 - Tata_Chemicals_yearly-reports-2017-18
P. 143

6WDWHPHQW RI 3URȴW DQG /RVV IRU WKH \HDU HQGHG    0DUFK

                                                                                                         ` in crore
                                                                              Note      Year ended    Year ended
                                                                                     31 March, 2018  31 March, 2017
          I.   Revenue from operations                                        24           3,524.17      3,837.04
          II.  Other income                                                   25            194.49         176.92
          III.  Total income (I+II)                                                       3,718.66       4,013.96
          IV.  Expenses
               a)  Cost of materials consumed                                               531.39         479.95
               b)  Purchases of stock-in-trade                                              218.58         448.96
               c)  Changes in inventories of finished goods, work-in-progress and stock-in-trade   (1.97)    39.95
               d)  Excise duty on sale of goods                                              58.16         230.24
               e)  Employee benefits expense                                   26            258.03         266.66   Integrated Report
               f)  Finance costs                                              27             86.51         100.98
               g)  Depreciation and amortisation expense                      28            126.55         129.60
               h)  Other expenses                                             29           1,537.82      1,513.61
               Total expenses (a to h)                                                    2,815.07       3,209.95
          V.   Profit before tax ( III - IV )                                               903.59        804.01
          VI.  Tax expense
               (a)  Current tax                                               30            245.60         241.71
               (b)  Deferred tax                                              30             33.52         (16.94)
               Total tax expense (VI (a) + VI (b))                                          279.12        224.77
          VII.  Profit for the year from continuing operations  ( V-VI)                     624.47        579.24
          VIII.  Profit before tax from discontinued operations                31            437.72         185.59
          IX.  Exceptional gain (net)                                         31           1,213.99            -
          X.   Tax expense of discontinued operations                         31            509.22          72.12
          XI.  Profit for the year from discontinued operations  ( VIII+IX-X)             1,142.49        113.47    Statutory Reports
          XII.  Profit for the year (VII+XI)                                              1,766.96        692.71
          XIII. Other comprehensive income (net of tax) (“OCI”)
               (A)  Items that will not be reclassified to the Statement of Profit and Loss
                   -   Changes in fair value of investments in equities carried at fair value through    1,019.25    410.68
                     OCI
                   -   Remeasurement of defined employee benefit plans (note 34)               32.92         (49.74)
               (B)  Income tax relating to items that will not be reclassified to the Statement of    (20.59)   17.22
                   Profit and Loss
               Total other comprehensive income (net of tax) (A-B)                        1,031.58        378.16
          XIV. Total comprehensive income for the year (XII + XIII)                       2,798.54       1,070.87
          XV.  Earnings per share for continuing operations (in `)
               -   Basic and Diluted                                          32             24.51          22.74
          XVI. Earnings per share for discontinued operations (in `)
               -   Basic and Diluted                                          32             44.85          4.45    Financial Statements
          XVII. Earnings per share (for continuing and discontinued operations) (in `)
               -   Basic and Diluted                                          32             69.36          27.19
               Notes forming part of the financial statements                 1-42
          As per our report of even date attached                       For and on behalf of the Board
          For B S R & Co. LLP                                           Bhaskar Bhat       Director
          Chartered Accountants                                         Nasser Munjee      Director
          Firm’s Registration No: 101248W/W - 100022                    Dr. Y. S. P. Thorat  Director
                                                                        Vibha Paul Rishi   Director
                                                                        S. Padmanabhan     Director
                                                                        Padmini Khare Kaicker  Director
          Vijay Mathur                    John Mulhall  Chief Financial Officer  R. Mukundan  Managing Director and CEO
          Partner                         Rajiv Chandan  General Counsel &    Zarir Langrana  Executive Director
          Membership No. 046476                       Company Secretary
          Mumbai, 18 May, 2018



                                                                               Standalone Financial Statements  141
   138   139   140   141   142   143   144   145   146   147   148